未登录

S

Stephan Menne

georgetown university

H指数:30

被引数:2,708

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain Diverse RNA Types Produced by HBV Replication or Derived from Integrated HBV DNA

JOURNAL OF VIROLOGY

IF3.8

2023-03-3010

OA

Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles

SCIENCE ADVANCES

IF12.5

2022-08-0521

OAAI

Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B

IF3.5

2022-08-036

OAAI

Constrained evolution of overlapping genes in viral host adaptation: Acquisition of glycosylation motifs in hepadnaviral precore/core genes

IF4.9

2022-07-284

OAAI

Host cell-dependent late entry step as determinant of hepatitis B virus infection

IF4.9

2022-06-179

OAAI

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-05-235

OAAI

Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-10-046

OAAI

Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks

IF5.2

2021-09-057

OAAI

Characterization and Application of Precore/Core-Related Antigens in Animal Models of Hepatitis B Virus Infection

IF15.8

2021-07-2320

OAAI

Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in Woodchucks

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-07-223

OAAI

Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B

IF3.5

2021-04-098

OAAI

Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

IF15.8

2020-11-2761

OAAI

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon-α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus

HEPATOLOGY COMMUNICATIONS

IF4.6

2020-04-2214

OAAI

Suitability of the woodchuck HCC as a preclinical model for evaluation of intra-arterial therapies

ANIMAL MODELS AND EXPERIMENTAL MEDICINE

IF3.4

2020-02-098

OAAI

Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks

IF4.9

2019-12-2319

OAAI

Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus

HEPATOLOGY COMMUNICATIONS

IF4.6

2019-07-0827

OAAI

Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B

CURRENT OPINION IN VIROLOGY

IF5.1

2018-06-0142

OAAI

Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes

IF3.4

2017-03-0617

OAAI

Sustained efficacy and surface antigen seroconversion in the woodchuck model of chronic hepatitis B with the selective toll-like receptor 8 agonist GS-9688

JOURNAL OF HEPATOLOGY

IF33

2017-01-0118

PREAI

Antiviral efficacy of a novel hepatitis B virus expression inhibitor in combination with entecavir and wIFN-alpha in woodchucks model of chronic hepatitis B

JOURNAL OF HEPATOLOGY

IF33

2017-01-016

PREAI